Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | APP | P05067 | 1/20 | 0.41 |
| ▸ | TDP2 | O95551 | 1/20 | 0.41 |
| ▸ | SMN1; SMN2 | Q16637 | 1/20 | 0.37 |
| ▸ | PNMT | P11086 | 2/20 | 0.36 |
| ▸ | ASIC3 | Q9UHC3 | 1/20 | 0.36 |
| ▸ | AVPR1A | P37288 | 1/20 | 0.36 |
| ▸ | CMA1 | P23946 | 1/20 | 0.35 |
| ▸ | AHR | P35869 | 1/20 | 0.35 |
| ▸ | METAP1 | P53582 | 1/20 | 0.34 |
| ▸ | PKM | P14618 | 2/20 | 0.34 |
| ▸ | PARP10 | Q53GL7 | 2/20 | 0.33 |
| ▸ | PARP11 | Q9NR21 | 1/20 | 0.33 |
| ▸ | ADRA2A | P08913 | 1/20 | 0.33 |
| ▸ | ADRA2B | P18089 | 1/20 | 0.33 |
| ▸ | ADRA2C | P18825 | 1/20 | 0.33 |
| ▸ | LMNA | P02545 | 1/20 | 0.33 |
| ▸ | MAPT | P10636 | 1/20 | 0.33 |
| ▸ | HTT | P42858 | 1/20 | 0.33 |
| ▸ | BLM | P54132 | 1/20 | 0.33 |
| ▸ | PARP1 | P09874 | 1/20 | 0.33 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL3990720 | 0.85 | APP (0.40) | APPTDP2SMN1; SMN2PNMTASIC3 | |
| SCHEMBL6652414 | 0.85 | APP (0.40) | APPTDP2SMN1; SMN2PNMTASIC3 | |
| SCHEMBL18926266 | 0.84 | APP (0.45) | APPTDP2SMN1; SMN2PNMTASIC3 | |
| SCHEMBL29500687 | 0.78 | AHR (0.46) | TDP2CMA1AHRPKMPARP10 | |
| SCHEMBL21061577 | 0.78 | AHR (0.46) | TDP2CMA1AHRPKMPARP10 | |
| SCHEMBL1758994 | 0.77 | LMNA (0.40) | APPTDP2SMN1; SMN2AHRLMNA | |
| SCHEMBL3707907 | 0.76 | CA9 (0.38) | APPTDP2SMN1; SMN2LMNAMAPT | |
| SCHEMBL22567805 | 0.74 | TDP2 (0.40) | APPTDP2PNMTASIC3CMA1 | |
| SCHEMBL24275671 | 0.74 | TDP2 (0.41) | APPTDP2PNMTASIC3CMA1 | |
| SCHEMBL1979578 | 0.73 | POLB (0.37) | TDP2SMN1; SMN2AVPR1ALMNAHTT |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 8 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-9598639-B2 | Liquid-crystal compound, liquid-crystal composition and liquid-crystal display device | DAXIN MATERIALS CORPORATION (TW) | 2017-03-21 | — | — | US | disclosed |
| US-9598639-B2 | Liquid-crystal compound, liquid-crystal composition and liquid-crystal display device | DAXIN MATERIALS CORPORATION (TW) | 2017-03-21 | — | — | US | disclosed |
| US-20160024384-A1 | LIQUID-CRYSTAL COMPOUND, LIQUID-CRYSTAL COMPOSITION AND LIQUID-CRYSTAL DISPLAY DEVICE | DAXIN MATERIALS CORPORATION (TW) | 2016-01-28 | — | — | US | disclosed |
| US-20160024384-A1 | LIQUID-CRYSTAL COMPOUND, LIQUID-CRYSTAL COMPOSITION AND LIQUID-CRYSTAL DISPLAY DEVICE | DAXIN MATERIALS CORPORATION (TW) | 2016-01-28 | — | — | US | disclosed |
| US-8388861-B2 | Liquid crystal compound and liquid crystal mixture | JIANGSU HECHENG DISPLAY TECHNOLOGY CO., LTD. (CN) | 2013-03-05 | — | — | US | disclosed |
| US-8388861-B2 | Liquid crystal compound and liquid crystal mixture | JIANGSU HECHENG DISPLAY TECHNOLOGY CO., LTD. (CN) | 2013-03-05 | — | — | US | disclosed |
| US-20120132854-A1 | LIQUID CRYSTAL COMPOUND AND LIQUID CRYSTAL MIXTURE | JIANGSU HECHENG CHEMICAL MATERIALS CO., LTD. (CN) | 2012-05-31 | — | — | US | disclosed |
| US-20120132854-A1 | LIQUID CRYSTAL COMPOUND AND LIQUID CRYSTAL MIXTURE | JIANGSU HECHENG CHEMICAL MATERIALS CO., LTD. (CN) | 2012-05-31 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20120132854-A1 | LIQUID CRYSTAL COMPOUND AND LIQUID CRYSTAL MIXTURE | CPNE4, LEO1, NCAPD3 | APP 1519/4885TDP2 4503/4885SMN1; SMN2 3304/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.